Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Heron Therapeutics Announces New CEO and Board Chairman
Heron Therapeutics, a commercial-stage biotechnology company focused on improving the lives of patients by developing […]
BioSenic Appoints Lieven Huysse, MD, as Chief Medical Officer (CMO)
BioSenic, the company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces […]
SynAct Pharma Appoints Torbjørn Bjerke as New CEO
SynAct Pharma has announced the appointment of the company’s current Chairman Torbjørn Bjerke MD, as […]
Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions
Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]
Sensorion Appoints Khalil Barrage as Interim Chairman of the Board
Sensorion, a pioneering clinical-stage biotechnology company that specializes in gene therapies in the ear, announces […]
Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors
Glyscend Therapeutics, a clinical-stage biotechnology company pioneering a new generation of orally administered polymer therapies, […]
Xeris Biopharma Appoints Ricki Fairley to Board of Directors
Xeris Biopharma, a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing […]
Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division
Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today […]
Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors
Aadi Bioscience, a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined […]
Meliora Therapeutics Appoints Claudio Chuaqui as Head of Drug Discovery
Meliora Therapeutics, a biotech company pioneering a machine learning-driven approach to mechanism-driven oncology drug development, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more